Evidence map›Paper›PMID 39054504›Full record

ArticleBMC public health2024

Social, economic, and physical side effects impact PrEP uptake and persistence among transgender women in Peru.

Sarah Naz-McLean, Jesse Clark, Leyla Huerta, Kenneth H Mayer, Javier R Lama, Sari Reisner, Amaya Perez-Brumer

Abstract read
In one paragraph

Article in BMC public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sarah Naz-McLeanDepartment of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Health Sciences Building 155 College Street, Toronto, ON, M5T 3M7, Canada. sarah.nazmclean@mail.utoronto.ca.
Jesse ClarkDepartment of Medicine, Division of Infectious Diseases, University of California Los Angeles David Geffen School of Medicine, Los Angeles, CA, USA.
Leyla HuertaFéminas, Lima, Peru.
Kenneth H MayerThe Fenway Institute, Fenway Health, Boston, MA, USA.
Javier R LamaAsociacion Civil Impacta Salud y Educacion, Lima, Peru.
Sari ReisnerThe Fenway Institute, Fenway Health, Boston, MA, USA.
Amaya Perez-BrumerDivision of Social and Behavioural Health, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Funding

STI Screening as a Combined HIV Prevention Platform for MSM in PeruR34MH105272 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CLARK, JESSE LAWTON · 2015 to 2017
$604k
NIH HHS R34 MH105272NIMH NIH HHS R34 MH105272
6 · The paper itself

Abstract

introductionOral pre-exposure prophylaxis (PrEP) for HIV-1 infection is over 99% effective in protecting against HIV acquisition when used consistently and appropriately. However, PrEP uptake and persistent use remains suboptimal, with a substantial gap in utilization among key populations who could most benefit from PrEP. In Latin America specifically, there is poor understanding of barriers to PrEP uptake and persistence among transgender (trans) women.

methodsIn April-May 2018, we conducted qualitative interviews lasting 25-45 min as part of an end-of-project evaluation of TransPrEP, a pilot RCT that examined the impact of a social network-based peer support intervention on PrEP adherence among trans women in Lima, Peru. Participants in the qualitative evaluation, all adult trans women, included individuals who either (1) screened eligible to participate in the TransPrEP pilot, but opted not to enroll (n = 8), (2) enrolled, but later withdrew (n = 6), (3) were still actively enrolled at the time of interview and/or successfully completed the study (n = 16), or (4) were study staff (n = 4). Interviews were audio recorded and transcribed verbatim. Codebook development followed an immersion/crystallization approach, and coding was completed using Dedoose.

resultsEvaluation participants had a mean age of 28.2 years (range 19-47). When describing experiences taking PrEP, participant narratives highlighted side effects that spanned three domains: physical side effects, such as prolonged symptoms of gastrointestinal distress or somnolence; economic challenges, including lost income due to inability to work; and social concerns, including interpersonal conflicts due to HIV-related stigma. Participants described PrEP use within a broader context of social and economic marginalization, with a focus on daily survival, and how PrEP side effects negatively contributed to these stressors. Persistence was, in some cases, supported through the intervention's educational workshops.

conclusionThis research highlights the ways that physical, economic, and social side effects of PrEP can impact acceptability and persistence among trans women in Peru, amplifying and layering onto existing stressors including economic precarity. Understanding the unique experiences of trans women taking PrEP is crucial to informing tailored interventions to improve uptake and persistence.

Indexed as

HIV InfectionsPre-Exposure ProphylaxisQualitative ResearchTransgender PersonsAdultAnti-HIV AgentsDrug MonitoringFemaleHumansInterviews as TopicMaleMedication AdherenceMiddle AgedPeruPilot ProjectsSocioeconomic FactorsAnti-HIV AgentsHIVPeruPrEPTransgender women

Identifiers

PMID39054504
PMCPMC11270771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.